doi: 10.1016/j.biopha.2024.117748, 66 LeiS.LiJ.YuJ.LiF.PanY.ChenX.et al
Lixisenatide, a GLP-1R agonist, reduces neurofibrillary tangles and amyloid plaque load, and thereby ameliorates learning memory deficits in APP/PS1 mice (144, 157)
do not use if you have a history of severe gastrointestinal disease Signs of low blood sugar, for example: dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness
Tyrosinase, a crucial enzyme in the synthesis of melanin, is inhibited
Related Stories Autolomous and Cellular Origins expand platform integration to deliver end-to-end cell therapy manufacturing orchestration Chrononutrition shows promise for postpartum weight management Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations Self-reports of liraglutide adherence were similarly high